For pharmaceutical formulators, nutraceutical manufacturers, and dietary supplement developers, the selection of capsule material is a critical decision that impacts product acceptance across diverse consumer populations. Traditional gelatin capsules, derived from animal collagen, present limitations for vegetarian and vegan consumers, those with religious dietary restrictions, and individuals with sensitivities to animal proteins. Beyond demographic considerations, gelatin capsules also exhibit stability challenges with hygroscopic or moisture-sensitive fill materials and may cross-link under certain storage conditions. Plant-based empty capsules, primarily made from hydroxypropyl methylcellulose (HPMC), address these limitations by offering a non-animal alternative with superior chemical stability, lower moisture content, and consistent dissolution profiles across a wider range of fill materials. As the global market for dietary supplements expands, as pharmaceutical development increasingly targets niche patient populations, and as consumer demand for clean-label, plant-based products intensifies, the market for plant-based empty capsules has grown significantly. Addressing these formulation and consumer acceptance imperatives, Global Leading Market Research Publisher QYResearch announces the release of its latest report “Plant-based Empty Capsules – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. This comprehensive analysis provides stakeholders—from pharmaceutical formulators and nutraceutical developers to contract manufacturing organizations and healthcare investors—with critical intelligence on a capsule category that is fundamental to the delivery of oral solid dosage forms across pharmaceutical and supplement markets.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098130/plant-based-empty-capsules
Market Valuation and Growth Trajectory
The global market for Plant-based Empty Capsules was estimated to be worth US$ 573 million in 2025 and is projected to reach US$ 862 million, growing at a CAGR of 6.1% from 2026 to 2032. In 2024, the global sales volume of enteric-coated hydroxypropyl methylcellulose (HPMC) empty capsules reached 173.1 billion capsules, with an average price of US$ 31 per 10,000 capsules. This steady growth trajectory reflects the expanding global market for dietary supplements, the increasing demand for vegetarian and vegan dosage forms, and the growing recognition of plant-based capsules’ superior stability characteristics for moisture-sensitive formulations.
Product Fundamentals and Technological Significance
Plant-based empty capsules are hollow capsules primarily made from plant-derived materials, commonly hydroxypropyl methylcellulose (HPMC) and other edible plant polysaccharides. Unlike traditional gelatin capsules, plant-based empty capsules contain no animal-derived ingredients, making them suitable for vegetarians and individuals with allergies to animal proteins. They offer excellent chemical stability and biocompatibility, providing a safe delivery vehicle for pharmaceuticals, dietary supplements, probiotics, enzymes, and other functional ingredients. Due to their natural and controllable composition, these capsules are widely used in pharmaceutical, nutraceutical, and functional food applications, particularly for oral dosage forms that require specific release sites and dissolution profiles.
The HPMC capsule offers distinct advantages over traditional gelatin alternatives. Chemically, HPMC is a semisynthetic polymer derived from cellulose, the most abundant natural polymer on earth. Unlike gelatin, which has a moisture content of 13-16%, HPMC capsules typically contain 3-7% moisture, making them significantly more compatible with moisture-sensitive fill materials such as probiotics, enzymes, and hygroscopic pharmaceutical actives. The lower moisture content reduces the risk of cross-linking—a phenomenon where gelatin capsules can form insoluble films during storage—ensuring consistent dissolution and bioavailability. HPMC capsules also demonstrate stability across a wider pH range and are less susceptible to degradation under temperature fluctuations. For delayed-release applications, enteric-coated HPMC capsules provide targeted delivery to the intestine without the risk of premature dissolution in the stomach, enabling formulations for acid-sensitive actives.
Market Segmentation and Application Dynamics
Segment by Type (Capsule Size):
- 00# — Represents the largest size, used for high-dose formulations and large-volume dietary supplements.
- 0# — Represents a commonly used size for pharmaceutical and nutraceutical applications, balancing dose capacity with swallowing convenience.
- 1# — Represents a mid-size capsule widely used for both pharmaceutical and supplement applications.
- 2# — Represents a smaller size for lower-dose formulations and pediatric applications.
- 3# — Represents a small-size capsule for low-dose actives and specialty applications.
- Others — Includes size 4, size 5, and specialty sizes for specific applications.
Segment by Application:
- Pharmaceuticals — Represents a significant segment for prescription and over-the-counter drugs requiring capsule dosage forms. Pharmaceutical applications demand stringent quality control, stability data, and regulatory compliance with pharmacopoeial standards (USP, EP, JP).
- Health Supplements — Represents the largest and fastest-growing segment, encompassing vitamins, minerals, herbal supplements, probiotics, and functional ingredients. The supplement market drives demand for vegetarian/vegan labeling and clean-label formulations.
- Others — Includes nutraceuticals, functional foods, and emerging applications.
Competitive Landscape and Geographic Concentration
The plant-based empty capsule market features a competitive landscape dominated by global capsule manufacturers with established pharmaceutical quality systems and significant production capacity. Key players include Qualicaps, Lonza, ACG Associated Capsules, Suheung, CapsCanada, Sunil Healthcare, Evonik Specialty Chemicals, Shandong Healsee Capsule, Anhui Huangshan Capsule, Farmacapsulas, Guangzhou Jiuzhou Capsule, Hunan Er-Kang Pharmaceutical, Hebei Kangxin Plant Capsule, Zhejiang Yueshan Capsule, Zhejiang Tianlong Capsule, Zhejiang Xinchang Kangping Capsule, Jiangsu Kangyoujian Biotechnology, Guizhou Guang De Li Pharmaceuticals, SUZHOU CAPSUGEL, Chongqing Heng Sheng Pharmaceutical, Jiangsu Youli Capsule, and Jinan Gaohua Medicinal Capsule.
A distinctive characteristic of this market is the geographic concentration of capsule manufacturing in Asia, particularly China and India, alongside European and North American manufacturers serving premium and specialty markets. Lonza (formerly Capsugel) and Qualicaps represent the global leaders with comprehensive product portfolios, regulatory expertise, and worldwide distribution networks. Chinese manufacturers—including Shandong Healsee, Anhui Huangshan, and Zhejiang Yueshan—have captured significant domestic and export market share through cost-competitive offerings and capacity expansion, serving the rapidly growing Chinese and global supplement markets.
Exclusive Industry Analysis: The Divergence Between Pharmaceutical and Nutraceutical Capsule Requirements
An exclusive observation from our analysis reveals a fundamental divergence in plant-based capsule requirements between pharmaceutical and nutraceutical applications—a divergence that reflects different regulatory oversight, stability requirements, and market dynamics.
In pharmaceutical applications, plant-based capsules must meet stringent regulatory requirements including USP <701> (Disintegration), <711> (Dissolution), and stability testing protocols. A case study from a global pharmaceutical manufacturer illustrates this segment. The manufacturer specifies HPMC capsules for its probiotic product line, requiring documented stability data across a range of temperature and humidity conditions, compatibility testing with the moisture-sensitive active, and regulatory filings. Capsule suppliers must provide DMF documentation, stability support, and GMP manufacturing.
In nutraceutical applications, plant-based capsules are valued for their vegetarian/vegan positioning and clean-label appeal, with emphasis on cost efficiency and supply chain reliability. A case study from a large dietary supplement brand illustrates this segment. The brand uses HPMC capsules across its vitamin and supplement line, leveraging the vegetarian positioning for marketing differentiation. While capsules must meet quality standards, the regulatory requirements are less stringent than pharmaceuticals, enabling use of a broader range of suppliers and cost-optimized sourcing strategies.
Technical Challenges and Innovation Frontiers
Despite market growth, plant-based empty capsules face persistent technical challenges. Formulation compatibility with certain lipophilic or hydrophobic fill materials may require specialized capsule formulations or processing conditions. Advanced capsule technologies including liquid-filled hard capsules and self-emulsifying formulations are expanding application possibilities.
Enteric coating technologies for HPMC capsules require specialized coating systems that maintain coating integrity while enabling targeted release. Advanced coating technologies are expanding delayed-release applications for plant-based capsules.
A significant technological catalyst emerged in early 2026 with the commercial validation of hypromellose capsules with integrated dissolution control, enabling tailored release profiles without separate enteric coating. These advanced capsules incorporate pH-sensitive polymers directly into the capsule shell, simplifying manufacturing and enabling new formulation approaches.
Policy and Regulatory Environment
Recent policy developments have influenced market trajectories. USP and EP monographs for HPMC capsules establish quality standards for pharmaceutical applications. Clean-label and natural product trends in the dietary supplement market drive demand for plant-based capsule options. Vegetarian and vegan labeling requirements in various markets influence capsule material selection for supplement products.
Regional Market Dynamics and Growth Opportunities
Asia-Pacific represents the largest and fastest-growing market for plant-based empty capsules, driven by China’s dominant supplement manufacturing base, India’s expanding pharmaceutical and supplement sectors, and growing domestic consumption of dietary supplements. North America and Europe represent significant markets, with strong demand for vegetarian/vegan dosage forms and premium supplement products.
For pharmaceutical formulators, nutraceutical manufacturers, contract manufacturing organizations, and healthcare investors, the plant-based empty capsule market offers a compelling value proposition: steady growth driven by supplement market expansion and vegetarian/vegan consumer preferences, essential dosage form for clean-label products, and innovation opportunities in controlled-release and specialized capsule technologies.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
